About Synthego
The Problem Synthego addresses a core hardware pain point: fragmented operations, slow decision cycles, and poor visibility across teams. Organizations in this market often rely on disconnected tools, which creates delays, revenue leakage, and inconsistent customer outcomes.
The Solution Synthego is a genome engineering company that enables access to CRISPR to accelerate life science R&D. Hardware Biotech In practice, Synthego centralizes critical workflows, automates repetitive coordination, and gives operators a real-time system of record. This reduces manual overhead and improves execution quality at scale.
Why it's growing With the rise of shifting customer expectations, faster digital adoption, and demand for measurable ROI, Synthego is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Culture The team operates in a fast-paced environment focused on hardware innovation, product velocity, and customer-centric execution. Their culture emphasizes ownership, experimentation, and measurable outcomes.
Why it Matters
Synthego matters now because with the rise of shifting customer expectations, faster digital adoption, and demand for measurable ROI, Synthego is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Funding Snapshot
- Series D • Founders Fund, $259M Series D in 2020
Hiring Roles
This company is actively hiring.
Meet the Founders
Synthego Team
Founder & CEO